RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

globe_newswire · 2026-08-25

$RNXT $PD $PK

PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial

Read the original at globe_newswire ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.